Acro Biomedical (ACBM) Change in Accured Expenses (2016 - 2025)
Acro Biomedical (ACBM) recorded quarterly Change in Accured Expenses of -$1315.0 in Q4 2025, down 105.62% quarter-over-quarter from $23404.0 in Q3 2025, and down 25.6% on a YoY basis from -$1767.4 in Q4 2024.
Acro Biomedical (ACBM) Change in Accured Expenses (2016 - 2025) Analysis & Trends
Acro Biomedical's Change in Accured Expenses history runs 10 years deep, the most recent figure standing at -$1315.0 for Q4 2025.
- In Q4 2025, Change in Accured Expenses fell 25.6% year-over-year to -$1315.0; the TTM figure through Dec 2025 stood at -$36878.0 (down 230587.5% YoY), while the FY2025 annual figure was -$36878.0, down 230587.5% from the prior year.
- Change in Accured Expenses was -$1315.0 for Q4 2025 at Acro Biomedical, down from $23404.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $65500.0 in Q3 2023 to a low of -$47685.0 in Q2 2025.
- Historically, Change in Accured Expenses has averaged $4353.8 across 5 years, with a median of $442.0 in 2024.
- The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses jumped 1010.17% in 2023, then plunged 10888.46% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at $4000.0 in 2021, then soared by 1291.78% to $55671.0 in 2022, then tumbled by 97.47% to $1408.0 in 2023, then plunged by 174.36% to -$1047.0 in 2024, then retreated by 25.6% to -$1315.0 in 2025.
- The last three Change in Accured Expenses figures came in at -$1315.0 (Q4 2025), $23404.0 (Q3 2025), and -$47685.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | 112,542.00 |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | 22,036.00 |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | 82,500.00 |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | 772,181.00 |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | 95,385.00 |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | -13,704.00 |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | -33,250.00 |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | 46,445.00 |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | 740,859.00 |
| 10 | Acro Biomedical | - | - | - | -1,315.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,315.00 |
| Dec 31, 2025 | -1,315.00 |
| Sep 30, 2025 | 23,404.00 |
| Sep 30, 2025 | 23,404.00 |
| Jun 30, 2025 | -47,685.00 |
| Jun 30, 2025 | -47,685.00 |
| Mar 31, 2025 | -11,282.00 |
| Mar 31, 2025 | -11,282.00 |
| Dec 31, 2024 | -1,047.00 |
| Dec 31, 2024 | -1,047.00 |
| Sep 30, 2024 | 2,771.00 |
| Sep 30, 2024 | 2,771.00 |
| Jun 30, 2024 | 442.00 |
| Jun 30, 2024 | 442.00 |
| Mar 31, 2024 | -2,150.00 |
| Mar 31, 2024 | -2,150.00 |
| Dec 31, 2023 | 1,408.00 |
| Dec 31, 2023 | 1,408.00 |
| Sep 30, 2023 | 65,500.00 |
| Sep 30, 2023 | 65,500.00 |